GlaxoSmithKline PLC — Investor Relations & Filings
Filings indexed
6,971
across all filing types
Latest filing
2026-05-14
Director's Dealing
Country
GB
United Kingdom
Listing
IL
GSK
GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director/PDMR Shareholding | 2026-05-14 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2026-05-14 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | |
| Director/PDMR Shareholding | 2026-05-11 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English |
Browse filings by year
18 years- 2026 229 filings
- 2025 709 filings
- 2024 332 filings
- 2023 304 filings
- 2022 416 filings
- 2021 350 filings
- 2020 337 filings
- 2019 337 filings
- 2018 352 filings
- 2017 355 filings
- 2016 527 filings
- 2015 397 filings
- 2014 569 filings
- 2013 727 filings
- 2012 472 filings
- 2011 400 filings
- 2010 157 filings
- 2009 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46076171 | Director/PDMR Shareholding | 2026-05-14 | English | ||
| 46121103 | DIRECTOR/PDMR SHAREHOLDING | 2026-05-14 | English | ||
| 44972608 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44972657 | Director/PDMR Shareholding | 2026-05-11 | English | ||
| 44939225 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44937480 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44894099 | Collaboration with CTTQ for bepirovirsen | 2026-05-11 | English | ||
| 44893790 | GSK - final tranche of share buyback programme | 2026-05-11 | English | ||
| 43058845 | 2026 AGM Resolutions | 2026-05-07 | English | ||
| 41940869 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-06 | English | ||
| 41943261 | Result of AGM | 2026-05-06 | English | ||
| 41452165 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-05 | English | ||
| 41417898 | Director/PDMR Shareholding | 2026-05-05 | English | ||
| 39541834 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-01 | English | ||
| 39539231 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-01 | English | ||
Financials
Loading financials…
We couldn't load the financials
No data available yet
We have extracted financials for GlaxoSmithKline PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
GlaxoSmithKline PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5262/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5262 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5262 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5262 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5262}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GlaxoSmithKline PLC (id: 5262)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.